首页> 外文期刊>International Journal of Surgery Case Reports >Case Report Thyroid papillary carcinoma with an insular component metastasizing to the sella turcica and sphenoid sinus: Case report
【24h】

Case Report Thyroid papillary carcinoma with an insular component metastasizing to the sella turcica and sphenoid sinus: Case report

机译:案例报告甲状腺乳头状癌,与罕有组分转移到Sella Turcica和Sphenoid Sinus:案例报告

获取原文
           

摘要

Introduction Papillary carcinoma accounts for approximately 80% of all thyroid carcinomas. It is associated with relatively good survival. Distant metastases occur in approximately 10% of the patients, with the lung and bone being the most commonly reported sites. We present a case of unusual metastasis to the sphenoid bone and sella turcica from papillary thyroid carcinoma with an insular component. Case presentation We present a case of 70 years old female patient who presents a voluminous goiter with an 11 cm mass of the left sixth rib. Trans-parietal biopsy proved its metastatic origin from a thyroid papillary carcinoma. The patient was treated with total thyroidectomy and radiation therapy as the metastatic tissue is radioiodine refractory. Pathology revealed a papillary carcinoma with an insular component. A year later, the patient develops another metastasis to the sphenoid bone extending to the sella turcica, cavernous sinus, and carotid arteries. Treatment was based on kinase inhibitor. Discussion Metastatic invasion of the skull develops in 2.5%–5.8% of differentiated thyroid carcinoma and mostly affects the sella turcica, pituitary gland, cavernous sinus and sphenoid sinus. The presence of an insular component in a well-differentiated thyroid carcinoma seems to be associated with a poor prognosis. For cases where the metastatic disease is found to be resistant to conventional therapies, some clinical trials show promise with the use of tyrosine kinase inhibitors such as Sorafenib. Conclusion Management of such uncommon cases remains challenging and should take in consideration evidence based guidelines, prognostic factors, disease progression path and treatment morbidity.
机译:引入乳头状癌占所有甲状腺癌的80%。它与相对良好的生存有关。远处转移发生在大约10%的患者中,肺和骨是最常见的网站。我们向Sphenoid Bone和Sella Turcica提供了一种与乳头状甲状腺癌的案例,具有绝大的组分。案例介绍我们提出了一个70岁的女性患者,呈现出一个带有11厘米左右的六肋骨的大量牛皮。反式旁白活组织检查证明了其从甲状腺乳头状癌中的转移起源。患者用总甲状腺切除术和放射治疗治疗,因为转移组织是放射性碘的难治性。病理学揭示了乳头状癌,含有绝大成分。一年后,患者将另一种转移发育给斯巴盂骨,延伸到Sella Turcica,海绵窦和颈动脉。治疗基于激酶抑制剂。讨论颅骨的转移性侵袭在分化的甲状腺癌的2.5%-5.8%中发育,大部分都会影响Sella Turcica,垂体腺,海绵窦和蝶窦。在良好分化的甲状腺癌中存在绝缘成分的存在似乎与预后差有关。对于发现转移性疾病对常规疗法抗性的情况下,一些临床试验显示使用酪氨酸激酶抑制剂如索拉非尼抑制剂。结论这种罕见案例的管理仍然具有挑战性,应考虑基于证据的准则,预后因素,疾病进展路径和治疗发病率。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号